Mirae Asset Global Etfs Holdings Ltd. Exact Sciences Corp Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Exact Sciences Corp stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 16,734 shares of EXAS stock, worth $949,152. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,734
Previous 21,186
21.01%
Holding current value
$949,152
Previous $917,000
3.05%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding EXAS
# of Institutions
651Shares Held
157MCall Options Held
1.43MPut Options Held
2.3M-
Capital World Investors Los Angeles, CA18.2MShares$1.03 Billion0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.9MShares$1.02 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$684 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12MShares$681 Million0.12% of portfolio
-
State Street Corp Boston, MA5.38MShares$305 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $10B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...